Daewon Pharmaceutical
대원제약 · 003220
Health Care Pharmaceuticals · KOSPI
Market cap US$133.6M (₩184.4B)
Overview
Daewon Pharmaceutical makes prescription and over-the-counter medicines, health supplements, and cosmetics, with products ranging from cold remedies and probiotics to sheet face masks.
It supplies hospitals, clinics, and pharmacies across South Korea, and also exports finished medicines and medical devices to international markets. Listed on KOSPI, South Korea's main stock exchange, the company operates across four segments, pharmaceuticals, cosmetics, health functional foods, and other services, and also manufactures medicines on a contract basis for other Korean pharmaceutical companies.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$381.8M
- FY2024US$433.5M
- FY2025US$438.7M
Operating profit
- FY2023US$23.4M
- FY2024US$20.4M
- FY2025US$2.5M
Net income
- FY2023US$17M
- FY2024US$6.6M
- FY2025−US$2.9M
Key ratios (FY2025)
Why it matters
Its cosmetics subsidiary SD Biotechnologies operates the 'SNP' brand, selling sheet masks and other skincare products in both domestic and overseas markets.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?